Skip to main navigation

About
- Board of Directors
- Leadership Team
Our Science
RNA Programs
Legacy Programs
- Bentrio Nasal Spray
- Inner Ear Therapeutics
Investors & Media

Contact us

About
- Board of Directors
- Leadership Team
Our Science
RNA Programs
Legacy Programs
- Bentrio Nasal Spray
- Inner Ear Therapeutics
Investors & Media

Contact us

Investors & Media

Events & Presentations

Upcoming Events
Past Events
Presentations

Altamira Therapeutics to Host 1st Half 2023 Financial Results and Business Update Call

Sep 12, 2023 8:00 AM EDT

Altamira Therapeutics to present at H.C. Wainwright 25th Annual Global Investment Conference

Sep 11, 2023 7:00 AM EDT

Meet Altamira: Fly exclusive interview with CEO Thomas Meyer

Aug 10, 2022

Supporting Materials

Altamira Therapeutics Sets Full Year 2021 Earnings Call

Apr 12, 2022 8:00 AM EDT

Supporting Materials

View Presentation 1.7 MB

Altamira Therapeutics to Present at the H.C. Wainwright BioConnect Conference, to be held virtually January 10-13, 2022

Jan 10 - Jan 13, 2022

Altamira Therapeutics to Host Conference Call and Webcast to Provide Business Update on Bentrio™ Program

Sep 27, 2021 2:00 PM CEST

Supporting Materials

Altamira Therapeutics Business Update September 2021 2.4 MB

Altamira Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference, to be held virtually September 13-15, 2021.

Sep 13 - Sep 15, 2021

Altamira Therapeutics to Report First Half 2021 Financial Results and Provide Business Update

Sep 8, 2021 3:00 PM CEST

Auris Medical Holding Ltd to hold the Special General Meeting

Jul 21, 2021 8:00 AM CEST

Supporting Materials

Auris Medical Notice of the SGM 2.4 MB

Auris Medical Holding to Present at LD Micro Invitational XI Conference

Jun 9, 2021 11:00 AM EDT

Pagination

Current page 1
Page 2
Next page
Last page

© Altamira Therapeutics 2023

Imprint | Privacy Notice | Terms of Use